Group 1 - The company held its first meeting of the fifth board of directors on June 11, 2025, with all nine directors present, and the meeting was deemed legal and effective [1][2]. - The board elected Chen Yong as the chairman of the fifth board of directors for a term of three years starting from the approval date [1][2]. - The board approved the election of committee members, including Chen Yong as the head of the strategy committee and Zhao Chen as the head of the audit committee, with all votes in favor [2]. Group 2 - The board appointed Chen Yong as the general manager, Chen Xinggen as the board secretary and deputy general manager, and several others as vice general managers and financial director, with unanimous approval [2][3]. - Chen Lijia was appointed as the securities affairs representative for a term of three years, also receiving unanimous support [3]. - The board proposed to provide a guarantee of up to 8 million yuan for the financing needs of its wholly-owned subsidiary, Sichuan Meidifa Medical Equipment Co., Ltd., with the guarantee valid for 12 months [3].

Meeting Details - The board meeting was held on June 11, 2025, with specific voting times for both network and internet voting [1] - A total of 66 shareholders and authorized representatives attended the meeting, representing 37,690,800 shares, which is 39.2436% of the total voting shares [1] Voting Results - The meeting adopted a combination of on-site and online voting, with 37,616,300 shares in favor of the proposals, accounting for the majority of the valid votes [2][3] - Among minority shareholders, 1,258,700 shares voted in favor, representing 94.4119% of the minority shareholder votes [2][3] - The total number of abstentions was 3,000 shares, with 200 shares defaulting to abstention due to non-voting [2][3] Election of Directors - The election of directors was conducted using a cumulative voting system, with results showing that several candidates were elected as non-independent directors [10][12] - Specific votes included 37,036,220 votes for one candidate, representing a significant majority of the voting shares [10] - The election results for minority shareholders indicated that 678,620 votes were cast for one candidate, which is 50.9016% of the minority shareholder votes [10] Legal Compliance - The meeting was witnessed by legal representatives from a law firm, confirming that the procedures followed were in compliance with relevant laws and regulations [13]

Core Viewpoint - The legal opinion issued by Beijing King & Wood Mallesons (Chengdu) Law Firm confirms that the procedures for convening and holding the 2024 annual general meeting of Sichuan Porton Medical Equipment Group Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its outcomes [1][2][3]. Group 1: Meeting Procedures - The annual general meeting is scheduled for June 11, 2025, and the notice for the meeting has been published in designated information disclosure media [3][4]. - The actual time, location, and method of the meeting align with the details provided in the notice [4]. Group 2: Attendance and Qualifications - A total of 66 participants attended the meeting, representing 37,690,800 shares, which accounts for 39.2436% of the total voting shares [5]. - The attendance included 53 shareholders participating via online voting, representing 655,100 shares, or 0.6821% of the total voting shares [5]. Group 3: Voting Procedures and Results - The meeting utilized a named voting method for the resolutions listed in the notice, with the results verified by shareholder representatives, supervisor representatives, and the law firm [7]. - The resolutions were passed with significant support, with 37,616,300 shares voting in favor, representing 99.8023% of the valid votes cast [7][9]. - The voting results for minority shareholders showed 1,258,700 shares in favor, accounting for 94.4119% of the votes from minority shareholders [9][10]. Group 4: Conclusion - The law firm concludes that the convening and holding of the meeting, the qualifications of attendees and conveners, as well as the voting procedures and results, are all in compliance with the relevant laws, regulations, and the company's articles of association [19][20].

Group 1 - The company completed the election of the fifth board of directors and appointed senior management and securities affairs representative [1][2] - The fifth board of directors consists of 9 members, with a term of three years starting from the approval date of the annual shareholders' meeting [1][2] - The board includes independent directors and employee representatives, ensuring compliance with regulations regarding board composition [2] Group 2 - The senior management team includes General Manager Chen Yong, Secretary of the Board Chen Xinggen, and Chief Financial Officer Zhang Qiu [3] - The securities affairs representative is Chen Lijia, who holds relevant qualifications [3][18] - The appointed senior management and securities affairs representative will serve a term of three years [3] Group 3 - The fourth supervisory board's term has expired, and three supervisors have stepped down but will continue to work in the company [4][5] - The departing supervisors include Shi Wencong, Li Lanying, and Chen Liangping, with their shareholdings disclosed [5]

一。 特此公告。 四川港通医疗设备集团股份有限公司董事会 证券代码：301515 证券简称：港通医疗 公告编号：2025-036 四川港通医疗设备集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）第四届董事会任 期于 2025 年 6 月 11 日届满。根据《公司法》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》及《公司章程》等有关规定，公司 第五届董事会由 9 名董事组成，其中 1 名为职工代表董事，由公司职工代表大会 选举产生。 公司于 2025 年 6 月 10 日在公司会议室召开了职工代表大会。经与会职工代 表认真讨论，会议选举魏勇先生为公司第五届董事会职工代表董事，职工代表董 事魏勇先生个人简历详见附件。 魏勇先生将与公司 2024 年年度股东会选举产生的 8 位董事共同组成公司第 五届董事会，任期与股东会选举产生的董事任期一致，自 2024 年年度股东会审 议通过之日起三年。魏勇先生担任职工代表董事后，公司董事会中兼任公司高 级管理人员以及由职工代表担 ...

Overview - The company plans to provide a guarantee of up to 8 million yuan for its wholly-owned subsidiary, Sichuan Meidifa Medical Equipment Co., Ltd., to support its daily operations and development needs [1][3]. Guarantee Details - The guarantee will be valid for 12 months from the date of the board's approval [1]. - The board has authorized the legal representative or designated agent to handle the necessary procedures related to the guarantee [1]. Financial Situation of the Subsidiary - As of March 31, 2025, Sichuan Meidifa Medical Equipment Co., Ltd. has total assets of 42.01 million yuan and total liabilities of 19.99 million yuan, resulting in a net asset value of 22.02 million yuan [2]. - The asset-liability ratio is reported at 47.58% [2]. - For the first quarter of 2025, the subsidiary reported an operating income of 3.07 million yuan and a net profit of 3.15 million yuan [2]. Board's Opinion - The board believes that the subsidiary has a good credit record and strong debt repayment capability, making the financial risk manageable [3]. - The guarantee is seen as beneficial for the subsidiary's operational and business development needs, enhancing its financing capacity [3]. Cumulative Guarantee Information - As of the announcement date, the total guarantee amount for the company and its subsidiaries is 8 million yuan, which is 0.62% of the company's latest audited net assets [3]. - There are no overdue guarantees or guarantees involving litigation against the company [3].

证券代码：301515 证券简称：港通医疗 公告编号：2025-035 四川港通医疗设备集团股份有限公司 关于完成董事会换届选举及聘任高级管理人 员、证券事务代表的公告 四川港通医疗设备集团股份有限公司（以下简称"公司"）于 2025 年 6 月 11 日召开职工代表大会选举产生了1名职工代表董事，并召开2024年年度股东会， 以累积投票方式审议通过了《关于董事会换届选举暨提名第五届董事会非独立董 事候选人的议案》《关于董事会换届选举暨提名第五届董事会独立董事候选人的 议案》，选举产生了公司第五届董事会董事；同日，公司召开了第五届董事会第 一次会议，审议通过了选举公司董事长、董事会各专门委员会委员及聘任公司高 级管理人员及证券事务代表等相关议案。公司第五届董事会换届选举已经完成， 现将相关情况公告如下。 一、第五届董事会及各专门委员会组成情况 （一）董事会成员 1、非独立董事：陈永先生、陈兴根先生、文再敏先生、陈叙先生、刘煜强 先生 2、职工代表董事：魏勇先生 3、独立董事：周正女士、赵尘女士、姚刚先生 公司第五届董事会成员由以上 9 名董事组成，任期三年，自 2024 年年度股 东会审议通过之日起至第五届董 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-032 四川港通医疗设备集团股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会未出现否决提案的情形。 2.本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1.会议召集人：四川港通医疗设备集团股份有限公司（以下简称"公司"） 董事会； 2.会议主持人：公司董事长陈永先生； 3.现场会议召开时间：2025年6月11日（星期三）下午14:00； 4.现场会议召开地点：四川省成都市简阳市凯力威工业大道南段356号公司 会议室； 5.网络投票时间： （1）通过深圳证券交易所交易系统进行网络投票的具体时间为2025年6月11 日的交易时间，即9:15-9:25，9:30—11:30和13:00—15:00； （2）通过深圳证券交易所互联网投票系统进行网络投票的开始时间为2025 年6月11日上午9:15，结束时间为2025年6月11日下午15:00。 6.召开方式：现场表决与网络投票相结合的方式。 7 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-034 2025 年 6 月 11 日，四川港通医疗设备集团股份有限公司（以下简称"公司"） 召开第五届董事会第一次会议审议通过了《关于 2025 年度拟向下属子公司提供 担保的议案》。为满足公司下属全资子公司四川美迪法医疗设备有限公司的日常 经营和发展需要，公司拟为四川美迪法医疗设备有限公司向金融机构申请的融资 授信业务提供不超过 800 万元的连带责任保证担保。担保额度有效期限自本次董 事会审议通过之日起 12 个月内。 本次担保事项在公司董事会审批权限范围内，无需提交股东会审议。公司董 事会授权公司法定代表人或指定的授权代理人办理具体手续，包括但不限于签署 前述担保额度内有关的合同、协议等各项法律文件，授权有效期与上述额度有效 期一致。 二、担保额度预计情况 | 担保方 | 被担保方 | 担保 方持 | 被担保方最 近一期经审 | 截至目 前担保 余额 | 2025 年 担保额 | 担保额度占 公司最近一 | 是否 关联 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 股比 ...

为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1． 经公司 2023 年年度股东大会审议通过的《四川港通医疗设备集团股份有 限公司章程》（以下简称《公司章程》）； 2． 公司 2025 年 4 月 21 日、2025 年 5 月 22 日刊登于深圳证券交易所网站 等中国证监会指定信息披露媒体的《第四届董事会第十九次会议决议公告》《第四 届董事会第二十次会议决议公告》； 3． 公司 2025 年 4 月 21 日刊登于深圳证券交易所网站等中国证监会指定信 息披露媒体的《第四届监事会第十九次会议决议公告》； 北京金杜（成都）律师事务所 关于四川港通医疗设备集团股份有限公司 2024 年年度股东会之法律意见书 致：四川港通医疗设备集团股份有限公司 北京金杜（成都）律师事务所（以下简称本所）接受四川港通医疗设备集团股 份有限公司（以下简称公司）委托，根据《中华人民共和国证券法》（以下简称《证 券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券监督管理委员 会《上市公司股东会规则》（以下简称《股东会规则》）等中华人民共和国境内（以 下简称中国境内，为本法律意见书之目的，不包括中国 ...